Superior Vena Cava syndrome: A contemporary review of a historic disease

Cardiology in Review

Volumn 17, Issue 1, 2009, Pages 16-23

  Cheng, Susan ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Superior vena cava; Superior vena cava syndrome; Vascular disease

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DEXAMETHASONE; DIURETIC AGENT; FIBRINOLYTIC AGENT; STREPTOKINASE; UROKINASE;

ANTICOAGULANT THERAPY; CARDIOVASCULAR RISK; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEFIBRILLATOR; DIAGNOSTIC IMAGING; ECHOGRAPHY; EDEMA; FIBRINOLYTIC THERAPY; HUMAN; IN-STENT RESTENOSIS; INDWELLING CATHETER; INFECTION; LOW DRUG DOSE; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PACEMAKER; PATHOLOGICAL ANATOMY; PERCUTANEOUS THROMBECTOMY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REVASCULARIZATION; REVIEW; STENT; STENT THROMBOSIS; SUPERIOR CAVA VEIN SYNDROME; THROMBOSIS; VEIN RECONSTRUCTION; MEDIASTINUM TUMOR;

HUMANS; MEDIASTINAL NEOPLASMS; SUPERIOR VENA CAVA SYNDROME;

EID: 59849087967     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/CRD.0b013e318188033c     Document Type: Review

References (59)

1. Schraufnagel DE, Hill R, Leech JA, et al. Superior vena caval obstruction. Is it a medical emergency? Am J Med. 1981;70:1169-1174.
2. Saeed AI, Schwartz AP, Limsukon A. Superior vena cava syndrome (SVC syndrome): a rare cause of conjunctival suffusion. Mt Sinai J Med. 2006;73: 1082-1085.
3. Kishi K, Sonomura T, Mitsuzane K, et al. Self-expandable metallic stent therapy for superior vena cava syndrome: clinical observations. Radiology. 1993;189:531-535.
4. Kogon BE, Plattner C, Jennings S, et al. Cyanosis produced by superior vena caval stenosis. Ann Thorac Surg. 2008;85:1083-1085.
5. Greenwell MW, Basye SL, Dhawan SS, et al. Dialysis catheter-induced superior vena cava syndrome and downhill esophageal varices. Clin Nephrol. 2007;67:325-330.
6. Hunter W. History of aneurysm of the aorta with some remarks on aneurysm in general. Med Obser Inq. 1757;1:323-357.
7. McIntire FT, Sykes EM. Obstruction of the superior vena cava; a review of the literature and report of two personal cases. Ann Intern Med. 1949;30: 925-960.
8. Schechter MM. The superior vena cava syndrome. Am J Med Sci. 1954;227: 46-56.
9. Chen JC, Bongard F, Klein SR. A contemporary perspective on superior vena cava syndrome. Am J Surg. 1990;160:207-211.
10. Parish JM, Marschke RF Jr, Dines DE, et al. Etiologic considerations in superior vena cava syndrome. Mayo Clin Proc. 1981;56:407-413.
11. Kee ST, Kinoshita L, Razavi MK, et al. Superior vena cava syndrome: treatment with catheter-directed thrombolysis and endovascular stent placement. Radiology. 1998;206:187-193.
12. Schifferdecker B, Shaw JA, Piemonte TC, et al. Nonmalignant superior vena cava syndrome: pathophysiology and management. Catheter Cardiovasc Interv. 2005;65:416-423.
13. Rizvi AZ, Kalra M, Bjarnason H, et al. Benign superior vena cava syndrome: stenting is now the first line of treatment. J Vasc Surg. 2008;47:372-380.
14. Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore). 2006;85: 37-42.
15. Parsons JM, Qureshi SA, Ladusans EJ, et al. Doppler evaluation of superior caval venous pathways after Mustard and Senning operations. Int J Cardiol. 1990;27:19-26.
16. Bender HW Jr, Stewart JR, Merrill WH, et al. Ten years' experience with the Senning operation for transposition of the great arteries: physiological results and late follow-up. Ann Thorac Surg. 1989;47:218-223.
17. Koyanagi T, Minami K, Tenderich G, et al. Thoracic and cardiovascular interventions after orthotopic heart transplantation. Ann Thorac Surg. 1999; 67:1350-1354.
18. Sze DY, Robbins RC, Semba CP, et al. Superior vena cava syndrome after heart transplantation: percutaneous treatment of a complication of bicaval anastomoses. J Thorac Cardiovasc Surg. 1998;116:253-261.
19. Sachdeva R, Seib PM, Burns SA, et al. Stenting for superior vena cava obstruction in pediatric heart transplant recipients. Catheter Cardiovasc Interv. 2007;70:888-892.
20. Zreik H, Bengur AR, Meliones JN, et al. Superior vena cava obstruction after extracorporeal membrane oxygenation. J Pediatr. 1995;127:314-316.
21. Khanna S, Sniderman K, Simons M, et al. Superior vena cava stenosis associated with hemodialysis catheters. Am J Kidney Dis. 1993;21:278-281.
22. Kitamura J, Murakami Y, Shimada T, et al. Morphological observation by intravascular ultrasound in superior vena cava syndrome after pacemaker implantation. Cathet Cardiovasc Diagn. 1996;37:83-85.
23. Goudevenos JA, Reid PG, Adams PC, et al. Pacemaker-induced superior vena cava syndrome: report of four cases and review of the literature. Pacing Clin Electrophysiol. 1989;12:1890-1895.
24. Bakken AM, Protack CD, Saad WE, et al. Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients. J Vasc Surg. 2007;45:776-783.
25. Harman M, Sayarlioglu M, Arslan H, et al. Fibrosing mediastinitis and thrombosis of superior vena cava associated with Behcet's disease. Eur J Radiol. 2003;48:209-212.
26. Mackie GC, Thomas A, Greenspan B, et al. Focal hepatic activity during ventilation-perfusion scintigraphy due to systemic-portal shunt due to superior vena cava obstruction from histoplasmosis-induced fibrosing mediastini-tis. Clin Nucl Med. 2007;32:707-710.
27. de Paiva TF Jr, Ribeiro HB, Campanholo CB, et al. Behcet's disease associated with superior vena cava syndrome without thrombosis. Clin Rheumatol. 2007;26:804-806.
28. Roguin A, Edelstein S, Edoute Y. Superior vena cava syndrome as a primary manifestation of Behcet's disease: a case report. Angiology. 1997;48:365-368.
29. Gaitini D, Beck-Razi N, Haim N, et al. Prevalence of upper extremity deep venous thrombosis diagnosed by color Doppler duplex sonography in cancer patients with central venous catheters. J Ultrasound Med. 2006;25:1297- 1303.
30. Reeves AR, Seshadri R, Trerotola SO. Recent trends in central venous catheter placement: a comparison of interventional radiology with other specialties. J Vasc Interv Radiol. 2001;12:1211-1214.
31. Zhan C, Baine WB, Sedrakyan A, et al. Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis. J Gen Intern Med. 2008;23(Suppl 1):13-19.
32. El Kababri M, El Khorassani M, Hessissen L, et al. Non-Hodgkin's lym-phoma with protein S deficiency. Arch Pediatr. 2004;11:29-32.
33. Preston CI, Poynton CH, Williams LB. Intermittent superior vena cava syndrome caused by a Hickman catheter. Clin Oncol (R Coll Radiol). 1992;4:60-61.
34. Garwood S, Flume PA, Ravenel J. Superior vena cava syndrome related to indwelling intravenous catheters in patients with cystic fibrosis. Pediatr Pulmonol. 2006;41:683-687.
35. Or I, Roguin N, Yahalom M, et al. Pacemaker implantation in a patient with a Behcet's disease associated with superior vena cava obstruction. Cardiovasc Intervent Radiol. 1986;9:13-14.
36. Wilson LD, Detterbeck FC, Yahalom J. Clinical practice. Superior vena cava syndrome with malignant causes. N Engl J Med. 2007;356:1862-1869.
37. Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: a systematic review. Clin Oncol (R Coll Radiol). 2002;14:338-351.
38. Kim HJ, Kim HS, Chung SH. CT diagnosis of superior vena cava syndrome: importance of collateral vessels. AJR Am J Roentgenol. 1993;161:539-542.
39. Eren S, Karaman A, Okur A. The superior vena cava syndrome caused by malignant disease. Imaging with multi-detector row CT. Eur J Radiol. 2006;59:93-103.
40. Lin EC, Quaife RA. FDG uptake in chronic superior vena cava thrombus on positron emission tomographic imaging. Clin Nucl Med. 2001;26:241- 242.
41. Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus. Cochrane Database Syst Rev. 2001:CD001316.
42. Sheikh MA, Fernandez BB Jr, Gray BH, et al. Endovascular stenting of nonmalignant superior vena cava syndrome. Catheter Cardiovasc Interv. 2005;65:405-411.
43. Gray BH, Olin JW, Graor RA, et al. Safety and efficacy of thrombolytic therapy for superior vena cava syndrome. Chest. 1991;99:54-59.
44. Guijarro Escribano JF, Anton RF, Colmenarejo Rubio A, et al. Superior vena cava syndrome with central venous catheter for chemotherapy treated successfully with fibrinolysis. Clin Transl Oncol. 2007;9:198 -200.
45. Greenberg S, Kosinski R, Daniels J. Treatment of superior vena cava thrombosis with recombinant tissue type plasminogen activator. Chest. 1991; 99:1298-1301.
46. Rantis PC Jr, Littooy FN. Successful treatment of prolonged superior vena cava syndrome with thrombolytic therapy: a case report. J Vasc Surg. 1994;20:108-113.
47. Chee CE, Bjarnason H, Prasad A. Superior vena cava syndrome: an increasingly frequent complication of cardiac procedures. Nat Clin Pract Cardiovasc Med. 2007;4:226-230.
48. Nagata T, Makutani S, Uchida H, et al. Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava. Cardiovasc Intervent Radiol. 2007;30:959- 967.
49. de Gregorio Ariza MA, Gamboa P, Gimeno MJ, et al. Percutaneous treatment of superior vena cava syndrome using metallic stents. Eur Radiol. 2003;13: 853-862.
50. Doty DB, Doty JR, Jones KW. Bypass of superior vena cava. Fifteen years' experience with spiral vein graft for obstruction of superior vena cava caused by benign disease. J Thorac Cardiovasc Surg. 1990;99:889-895; discussion 895-886.
51. Gloviczki P, Pairolero PC, Toomey BJ, et al. Reconstruction of large veins for nonmalignant venous occlusive disease. J Vasc Surg. 1992;16:750-761.
52. Seelig MH, Oldenburg WA, Klingler PJ, et al. Superior vena cava syndrome caused by chronic hemodialysis catheters: autologous reconstruction with a pericardial tube graft. J Vasc Surg. 1998;28:556 -560.
53. Billing JS, Sudarshan CD, Schofield PM, et al. Aortic arch homograft as a bypass conduit for superior vena cava obstruction. Ann Thorac Surg. 2003; 76:1296-1297.
54. Kalra M, Gloviczki P, Andrews JC, et al. Open surgical and endovascular treatment of superior vena cava syndrome caused by nonmalignant disease. J Vasc Surg. 2003;38:215-223.
55. Chiu CJ, Terzis J, MacRae ML. Replacement of superior vena cava with the spiral composite vein graft. A versatile technique. Ann Thorac Surg. 1974; 17:555-560.
56. Chiu RC. Spiral vein graft: a historical vignette. Can J Surg. 1998;41:8 -9.
57. Schainfeld RM. Turning the old school on its head: stenting as the therapy of choice for SVC syndrome. Catheter Cardiovasc Interv. 2005;65:424- 426.
58. Alimi YS, Juhan C. New trends in the surgical and endovascular reconstructions of large veins for nonmalignant chronic venous occlusive disease. Curr Opin Cardiol. 1998;13:375-383.
59. Stanford W, Jolles H, Ell S, et al. Superior vena cava obstruction: a venographic classification. AJR Am J Roentgenol. 1987;148:259-262.